Golimumab
- Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study. Berger et al., Ther Drug Monit. 2019 Aug;41(4):459-466. doi: 10.1097/FTD.0000000000000629. PMID: 30817702.
- Optimal concentration range of golimumab in patients with axial spondyloarthritis. MartÃnez-Feito et al., Clin Exp Rheumatol. 2018 Jan-Feb;36(1):110-114. Epub 2017 Sep 15. PMID: 28980904.
- Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis. Detrez et al., Crohns Colitis. 2016 May;10(5):575-81. doi: 10.1093/ecco-jcc/jjv241. Epub 2016 Jan 6. PMID: 26738756; PMCID: PMC4957447.
- Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice. Kneepkens et al., Ann Rheum Dis 2014; 73(12):2217-9.
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis. van Schouwenburg et al., Nat Rev Rheumatol 2013; 9(3):164-72. Epub 2013 Feb 12. Review.
